Literature DB >> 2614687

Determination of mean input time, mean residence time, and steady-state volume of distribution with multiple drug inputs.

N Watari1, L Z Benet.   

Abstract

A general treatment for determination of mean residence time (MRT) and steady-state volume of distribution (Vss) after multiple drug inputs via any mode of administration is presented. For multiple inputs, either simultaneous or consecutive, the mean input time (MIT) can be readily calculated using the general equations presented here. Sample calculations for MIT, MRT, and Vss following different combinations of multiple drug inputs are presented. Errors inherent in noncompartmental area determinations are discussed.

Mesh:

Year:  1989        PMID: 2614687     DOI: 10.1007/bf01071351

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  11 in total

1.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

2.  An integrated approach to pharmacokinetic analysis for linear mammillary systems in which input and exit may occur in/from any compartment.

Authors:  E Nakashima; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1989-12

3.  General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.

Authors:  L Z Benet
Journal:  J Pharm Sci       Date:  1972-04       Impact factor: 3.534

4.  General treatment of mean residence time, clearance, and volume parameters in linear mammillary models with elimination from any compartment.

Authors:  E Nakashima; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

5.  Noncompartmental determination of the steady-state volume of distribution for any mode of administration.

Authors:  D Perrier; M Mayersohn
Journal:  J Pharm Sci       Date:  1982-03       Impact factor: 3.534

6.  Model-independent steady-state volume of distribution.

Authors:  A B Straughn
Journal:  J Pharm Sci       Date:  1982-05       Impact factor: 3.534

7.  Steady-state volume of distribution after multiple doses.

Authors:  W L Hayton; P Haefelfinger
Journal:  J Pharm Sci       Date:  1985-10       Impact factor: 3.534

8.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

9.  Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

10.  Disposition kinetics of ethambutol in man.

Authors:  C S Lee; D C Brater; J G Gambertoglio; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1980-08
View more
  9 in total

1.  The relevance of residence time theory to pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  An integrated approach to pharmacokinetic analysis for linear mammillary systems in which input and exit may occur in/from any compartment.

Authors:  E Nakashima; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1989-12

3.  Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.

Authors:  J G Wagner; D A Ganes; K K Midha; I Gonzalez-Younes; J C Sackellares; L D Olson; M B Affrime; J E Patrick
Journal:  J Pharmacokinet Biopharm       Date:  1991-08

4.  Bioavailability and absorption kinetics of nicotine following application of a transdermal system.

Authors:  S K Gupta; N L Benowitz; P Jacob; C N Rolf; J Gorsline
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

5.  Physiological modeling of altered pharmacokinetics of a novel anticancer drug, UCN-01 (7-hydroxystaurosporine), caused by slow dissociation of UCN-01 from human alpha1-acid glycoprotein.

Authors:  E Fuse; A Hashimoto; N Sato; H Tanii; T Kuwabara; S Kobayashi; Y Sugiyama
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

6.  In vitro-in vivo studies of the quantitative effect of calcium, multivitamins and milk on single dose ciprofloxacin bioavailability.

Authors:  Baishakhi Dey; Prakash Katakam; Fathi H Assaleh; Babu Rao Chandu; Shanta Kumari Adiki; Analava Mitra
Journal:  J Pharm Anal       Date:  2015-03-10

7.  Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator.

Authors:  Selwyn J Hurwitz; Noreen McBrearty; Alla Arzumanyan; Eugene Bichenkov; Sijia Tao; Leda Bassit; Zhe Chen; James J Kohler; Franck Amblard; Mark A Feitelson; Raymond F Schinazi
Journal:  Viruses       Date:  2021-01-15       Impact factor: 5.048

8.  PKQuest: capillary permeability limitation and plasma protein binding - application to human inulin, dicloxacillin and ceftriaxone pharmacokinetics.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2002-09-26

9.  PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2002-08-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.